Evidence map›Paper›PMID 29026166›Full record

ArticleScientific reports2017

Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children.

Laura Matrajt, Soren Gantt, Bryan T Mayer, Elizabeth M Krantz, Jackson Orem, Anna Wald, Lawrence Corey, Joshua T Schiffer, Corey Casper

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Detection ofPathogens (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Laura MatrajtFred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID 0000-0003-4495-7245
Soren GanttFred Hutchinson Cancer Research Center, Seattle, WA, USA. sgantt@bcchr.ca.
Bryan T MayerFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Elizabeth M KrantzFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jackson OremUganda Cancer Institute, Makerere University, Kampala, Uganda.
Anna WaldFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lawrence CoreyFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Joshua T SchifferFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Corey CasperFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Fred Hutch Cancer Center · USUniversity of Washington · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAInfectious Disease Research Institute · USUganda Cancer Institute · UG

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
THE PERINATAL COMPLICATIONS OF ASYMPTOMATIC GENITAL HERPES SIMPLEX VIRUSP01AI030731 · NIAID · UNIVERSITY OF WASHINGTON · PI JOHNSTON, CHRISTINE MICHELLE · 1991 to 2017
$34.3M
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
Institute for Translational Health Science (KL2)KL2RR025015 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$9.3M
CYTOTOXIC T CELL RESPONSES TO HSV IN HIV INFECTIONR01AI042528 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE, ZHU, JIA · 1998 to 2016
$2.7M
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in AfricaR01CA138165 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CASPER, COREY · 2010 to 2014
$1.5M
NCATS NIH HHS KL2 TR002317NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA138165NCRR NIH HHS KL2 RR025015NIAID NIH HHS P01 AI030731NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI042528
6 · The paper itself

Abstract

Human herpesviruses (HHV) establish lifelong latent infection and are transmitted primarily via shedding at mucosal surfaces. Each HHV causes a unique spectrum of disease depending on the infected individual's age and immunity. We collected weekly oral swabs from young children and mothers in 32 Ugandan households for a median of one year. We characterized kinetics of oral shedding during primary and chronic infection for each virus. Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and HHV-6 were shed at high rates following primary infection. The rate of oral herpes simplex virus (HSV) shedding was lower overall, and children and mothers with chronic HSV infection had lower shedding rates than children with primary infection. CMV shedding rate and viral load were higher in children with primary infection compared to children with chronic infection, and even lower in mothers with chronic infection. HHV-6 shedding rate and viral load were similar between children with primary or chronic infection, but lower in mothers. EBV shedding rate and quantity decreased less dramatically in mothers versus children, with HIV-positive mothers shedding at a higher rate than HIV-negative mothers. Each HHV has a distinct pattern of oral shedding which depends partially on the age and immune status of the host.

Indexed as

ChildChild, PreschoolCytomegalovirusFemaleHerpes SimplexHerpesvirus 4, HumanHumansInfantInfant, NewbornKineticsMaleSimplexvirusViral Load

Identifiers

PMID29026166
PMCPMC5638921
OpenAlexW2763669316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.